Piotr Sawrycki - Beth Israel Deaconess Medical Center (D.F.M.), From Dana-Farber Cancer Institute and Harvard Medical School (T.K.C.)

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 19 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma

NEW ENGLAND JOURNAL OF MEDICINEno. 15 (2024): 1359-1371

Cited31Views0WOSBibtex

Xevinapant Plus Avelumab in Patients (pts) with Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC): Phase 1b Dose-Expansion Results and Exploratory Biomarker Analyses

Quincy Chu,Tudor Ciuleanu,Rodryg Ramlau,Daniel Renouf,Rosalyn Juergens,Ewa Kalinka,Piotr Sawrycki,Jonathan Bramson,Brad Nelson,Rafael Crabbe,Daniela A. Sahlender,Philippa Crompton,Elisabeth Rouits,Dany Spaggiari,Franck Brichory,Luke Piggott, Mike Schenker,Glenwood Goss

CANCER RESEARCHno. 8 (2023)

Cited0Views0Bibtex

Abstract CT202: Xevinapant Plus Avelumab in Patients (pts) with Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC): Phase 1b Dose-Expansion Results and Exploratory Biomarker Analyses

Quincy Chu,Tudor Ciuleanu,Rodryg Ramlau,Daniel Renouf,Rosalyn Juergens,Ewa Kalinka,Piotr Sawrycki,Jonathan Bramson,Brad Nelson,Rafael Crabbé,Daniela A. Sahlender,Philippa Crompton,Elisabeth Rouits,Dany Spaggiari,Franck Brichory,Luke Piggott, Mike Schenker,Glenwood Goss

Cancer Researchno. 8_Supplement (2023)

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn